Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Target-controlled Infusion of Propofol and Remifentanil for Postoperative Sedation Guided by the Bispectral Index: Comparison Between Manual Perfusion and Automated Perfusion

NCT00393003 is registered in ClinicalTrials.gov with Hopital Foch as lead sponsor.

NCT NCT00393003
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00393003 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Target-controlled Infusion of Propofol and Remifentanil for Postoperative Sedation Guided by the Bispectral Index: Comparison Between Manual Perfusion and Automated Perfusion
Lead sponsor
Hopital Foch
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2006
Completion date
April 30, 2007
Enrollment
32
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

postoperative sedation